“To speed up discovery and impact health, we must transform our approach to science. Innovations in biomedical science and big data technology have brought hope, and are powered by a new way of doing science: Open Science. This is the concept of freely sharing research data and materials, and removing barriers to collaboration.
We welcome you to engage and exchange around Open Science in action at The Neuro and beyond.
Meet and learn from national and international experts on intellectual property protocols, ethics, patient consent and engagement, pharma, neuroinformatics, and more!
The symposium will be moderated by Susan Usher, Director of the Health Innovation Forum. Our keynote speakers include John Wilbanks (Sage Bionetworks), Dario Taraborelli (Chan Zuckerberg Initiative), Russ Poldrack (Stanford Center for Reproducible Neuroscience), and Brian Wallach (I am ALS). We are also pleased to welcome Alain Schuhl (French National Centre for Scientific Research) and Suzana Petanceska (National Institute on Aging). The symposium will close with the Wilder Penfield Lecture, delivered by Susan M. Fitzpatrick, President of the James S. McDonnell Foundation. …”
“In order to survive in the modern scientific environment researchers need to publish. Jobs, grants and opportunities all hinge on publications, which impacts acutely upon early career researchers (ECRs), such as PhD students, who do not tend to have guaranteed employment. How is this publish or perish dilemma impacted by developments in research such as those offered by Open Science (OS)? OS presents an enormous shift in the way science is conducted and comprises a range of practices that promote transparency and reliability of research. These include data sharing and study preregistration. Although OS can offer new ways to publish, considerable resources are often required to complete studies using OS methods, that can limit or delay publications. At present, formal recognition of such efforts is sparse and the pressure to publish may be greater for ECRs who engage with OS. We discuss this challenge in light of different OS methods from our perspective as ECRs at different stages….
OS research practices might help to address the publish or perish dilemma for ECRs, if alternative ways of publishing are promoted. For example, OS practices allow ECRs to demonstrate productivity and research skills using preregistrations and RRs before final publication. Even code and materials are citable if researchers assign them digital object identifiers, ensuring recognisable research outputs. We make the following recommendations: …”
“Key to EOSC architecture is its sustainability, which will primarily be driven by: 1- a participatory design and governance to accommodate different needs and requirements, 2- shared investments as they are being developed by member states (MS/AC), 3- the ability to adapt to new technologies and foster innovation. It is therefore critical that EOSC architecture avoids at any cost a monolithic and centralized approach, and follow a “System of Systems” approach, where resources are brought together at different levels to deliver data and data services. Emphasis is therefore placed on a business-tobusiness (B2B) sharing (data, services, people) and access, with agreements on: 1- A shared policy compliance framework (i) dictating and applying the rules of how the data elements are published, shared and re-used, and (ii) implementing an interlinked data space where every research result comes with its context (related entities), provenance (full data and science path) and usage….
EOSC will converge national support structures bringing all players together in a collaborative arrangement. No single organization is able to fulfil the Commons approach alone and implementation of Open Science requires specific handling, as most of the barriers are cultural and organizational….
For Open Science to succeed in EOSC, we need to: i) provide services for all stakeholders involved in the research life cycle, ii) ensure data federation for both small and big data to become an integral part of EOSC, iii) embed services in institutional settings, and iv) link to international infrastructures. …”
“Our recently published position paper expresses our views on how to (i) strengthen and reinforce Open Science as the modus operandi in EOSC, and (ii) highlight the important role of open scientific communication as a vehicle to deliver Open Science in a trusted and reliable way.
“The European Open Science Cloud is a great and timely opportunity for coordinating our efforts to unleash Europe’s potential into making good use and adding value to research data. Collaboration and openness should be in the center to make EOSC work. Open Science – and particularly Open Access to scientific content (publications, data, software) – is now becoming all the more relevant, and we are pleased to see our work in OpenAIRE for the past 10 years fill this gap in EOSC. “ Natalia Manola, OpenAIRE Managing Director.
“This one-day FIT4RRI workshop will equip trainers to provide training on open and responsible research practices in their institution or community.
This train-the-trainer bootcamp will cover good practices of engaging and interactive training sessions. We will look at copyright and licensing issues as well as materials available to support your training events. In addition, we will exchange and practice how to give training. In the afternoon we will play the FOSTER train-the-trainer card game and you will work on your own Open Science and RRI mini-trainings….”
“Open Science concepts and tools have the potential to transform the current scientific system for the greater good of all, but what does it mean for you? How can you and your work benefit from the Open Science movement? Welcome to a workshop run by ORION Open Science.
This workshop will establish what Open Science is and why it is needed. There will be an overview of the main areas of Open Science: Open Access, Open Data, Public Engagement. Dr Kevin Kunzmann will share his experiences of Open Science and why he believes in the movement. In addition, there will be some practical tips on changes researchers can make towards Open Science, the potential career benefits of Open Science, and information on what resources the ORION project can provide. The session is suitable for those with very little or basic knowledge of open science….”
“ORION [Open Responsible research and Innovation to further Outstanding kNowledge] is a 4-year project (runs from May 2017 to April 2021) that has received funding from the European Union’s Horizon 2020 research and innovation programme under the Science with and for Society (SWAFS) Work Programme. The main aim of the SWAFS Programme is to build effective cooperation between science and society. Open science is a core strategy of the European Commission that involves widening participation and collaboration as well as sharing research processes and outcomes to improve research and innovation….”
“TextRelease together with Leading Organizations worldwide powers GreyNet and the International Conference Series on Grey Literature….”
“Who are clinical trials for – doctors, pharma companies or patients? Open Pharma believes that clinical trials are for everyone and that findings should be transparent and made accessible in a timely manner. To celebrate Open Access Week 2019, Open Pharma has teamed up with Pint of Science in a pioneer event titled ‘Clinical trial transparency – let’s talk’, which will take place on Wednesday 23 October from 19:30 to 21:30 at St Aldates Tavern in Oxford.
The event features highlights from the COMPare study presented by Dr Henry Drysdale and an overview of the progress Open Pharma has made so far and of its future goals. After a quick break to refill any empty pint glasses, audience members will have the chance to direct any questions to our expert panel, namely Professor Trish Greenhalgh, Nick DeVito, Joe Adams, Georgia Richards and Open Pharma’s own Tim Koder….”
“The Accelerating Medicines Partnership-Alzheimer’s Disease (AMP-AD) program’s open-science enterprise, which has provided more than 500 new candidate targets for Alzheimer’s disease, served as the foundation for the new centers.
“Through these centers, NIH will expand the use of open-science and open-source principles to de-risk novel drug targets with the goal of facilitating the development of new treatments for Alzheimer’s,” said NIH Director Francis S. Collins, M.D., Ph.D….”